• SENSEX 77,928.15
    273.55 (+0.35%)
  • BANKNIFTY 57,147.50
    -58.40 (--0.10%)
  • Indo-MIM
    757.50 757.50(%)
  • Bajaj Finserv
    1,891.35 1,598.15(%)
  • Bajaj Finance
    1,067.05 1,102.45(%)
  • ICICI Bank
    1,423.00 1,187.55(%)
  • HDFC Bank
    758.00 1,020.35(%)
  • Adani Green
    1,350.10 767.00(%)
  • Reliance Industries
    1,298.00 1,611.20(%)
  • DLF
    652.05 489.30(%)
  • TBO Tek
    1,473.20 1,005.50(%)
  • Eicher Motors
    7,929.00 8,232.80(%)
  • Kalyan Jewellers
    649.00 649.00(%)
  • M & M
    3,325.00 3,840.00(%)
  • TVS Motor Co.
    4,219.00 4,219.00(%)
  • Infosys
    1,187.00 1,727.85(%)
  • Coforge
    1,763.70 1,988.90(%)
  • Jubilant Food.
    433.80 408.50(%)
  • Waaree Energies
    2,563.00 2,402.00(%)
  • Cholaman.Inv.&Fn
    1,758.65 1,299.80(%)
  • Redington
    338.20 338.20(%)
  • SBI
    1,030.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unichem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 577.0
  • ISIN : INE351A01035
523.70 -10 (-1.79%)
  • As on 30 Jul 2026 (EOD)
  • Today’s Low

    515.05
  • Today’s High

    538.00
  • Open

    531.00
  • Perv Close

    533.25
  • 52W Low

    278.20
  • 52W High

    687.20

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,687.15

  • Div & Yield %

    0.00

  • Book Value(₹)

    373.14

  • Debt-Equity Ratio

    -1.79

  • AGM Date

    30-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    3,687.15

  • RONW (%)

    -1.79

  • ROCE (%)

    -0.23

Score Board

  • Equity (₹ in Cr.)

    14.08

  • BV (₹)

    373.10

  • Sales( ₹ in Cr.)

    1,412.29

  • NP (in Cr.)

    -15.57

  • NP Var(%)

    -110.0

  • Div%

    0.0

  • CPS (₹)

    14.70

  • EPS (₹)

    -2.20

  • Traded Value (₹ in Lakhs)

    3,683.63

  • 52 Week High

    687.20

  • 52 Week Low

    278.20

  • Price BSE

    523.0

  • Price NSE

    524.00

  • Market Capital( in Cr.)

    3,683.63

  • P/C Ratio

    35.60

  • P/E Ratio

    -236.50

  • Price Vs.BV

    -2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,412.29 1,735.70 1,442.16 1,072.43 942.93 1,123.97
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,412.29 1,735.70 1,442.16 1,072.43 942.93 1,123.97
Other Income 363.54 44.83 98.40 41.85 42.07 47.37
Stock Adjustments 7.28 33.33 26.35 -22.01 52.79 16.73
Total Income 1,783.11 1,813.86 1,566.91 1,092.27 1,037.79 1,188.07
EXPENDITURE :            
Raw Materials 672.64 830.62 717.82 501.86 436.27 449.67
Power and Fuel Cost 105.32 106.63 105.64 101.41 77.12 67.95
Employee Cost 277.22 287.51 283.15 270.86 250.79 234.04
Other Manufacturing Expenses 95.42 78.10 74.62 70.61 73.49 64.48
Selling and Administration Expenses 195.50 190.81 213.59 194.89 192.65 225.80
Miscellaneous Expenses 96.77 21.48 148.40 116.36 8.95 3.28
Employee Benefit Expenses 277.22 287.51 283.15 270.86 250.79 234.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,442.87 1,515.15 1,543.22 1,256.00 1,039.27 1,045.23
Operating Profit 340.24 298.71 23.69 -163.73 -1.49 142.84
Interest 11.80 7.62 10.42 9.38 2.07 1.30
Gross Profit 328.44 291.09 13.27 -173.11 -3.56 141.54
Depreciation 119.03 108.41 105.45 105.98 83.19 75.89
Profit Before Tax 209.41 182.68 -92.18 -279.09 -86.75 65.65
Current Tax 0.44 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 50.03 19.72 0.00 20.61 -31.32 11.56
Reported Net Profit 158.94 162.96 -92.18 -299.70 -55.43 54.08
Extraordinary Items 174.51 4.42 -55.94 -103.16 -0.25 0.02
Adjusted Net Profit -15.57 158.54 -36.24 -196.54 -55.18 54.06
Adjustment below Net Profit -1.38 0.00 0.00 121.81 0.00 0.00
P & L Balance brought forward 2,445.03 2,279.18 2,359.31 2,565.36 2,648.96 2,623.04
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 -2.89 -12.05 28.16 28.16 28.16
P & L Balance carried down 2,602.59 2,445.03 2,279.18 2,359.31 2,565.36 2,648.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 200.00 200.00 200.00
Dividend Per Share(Rs) 0.00 0.00 0.00 4.00 4.00 4.00
Earnings Per Share-Unit Curr 22.58 23.15 -13.09 -42.57 -7.87 7.68
Earnings Per Share(Adj)-Unit Curr 22.58 23.15 -13.09 -42.57 -7.87 7.68
Book Value 373.17 349.40 325.94 338.65 379.52 383.11
Book Value(Adj)-Unit Curr 373.17 349.40 325.94 338.65 379.52 383.11

Shareholding Pattern

  • Promoter Group

    70.22%

  • Public Share Holding

    29.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,221,224 17.36 12,221,224 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 37,219,362 52.86 37,219,362 4
Others 0 0.00 0 0
Sub Total 49,440,586 70.22 49,440,586 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 22,954 0.03 22,454 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 636,650 0.90 636,150 33
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 500 0.00 500 1
Insurance Companies 153,628 0.22 153,628 2
Mutual Funds / UTI 6,560,243 9.32 6,560,243 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 625,664 0.89 625,664 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,999,639 11.36 7,998,639 47
2] Non Institution
Bodies Corporate 278,962 0.40 278,882 138
Clearing Members 24,413 0.03 24,413 16
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 487,442 0.69 485,442 546
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 427,281 0.61 427,281 702
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,494,767 2.12 826,642 5
Individuals holding nominal share capital up to Rs. 1 lakh 9,478,141 13.46 8,866,852 23,868
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,000 0.01 4,000 1
Others 730,043 1.04 730,043 1
Sub Total 12,965,525 18.42 11,684,031 25,292
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 70,405,750 100.00 69,123,256 25,347

Company Background

Unichem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Unichem Laboratories Ltd
  • BSE Code : 577.0
  • ISIN : INE351A01035
  • Incorporation Year

    1962

  • Registered Office

    47 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474100

  • FAX

  • Chairman

    Prakash A Mody

  • Managing Director

    Pabitra Bhattacharya

  • Company Secretary

  • Auditor

    N A Shah Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Unichem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unichem Labs. 523.20 1,475.19 1,412.29 23.18 -0.12
Abbott India 27,566.00 7,217.19 6,929.05 37.74 43.78
Astrazeneca Phar 8,090.05 2,304.07 2,275.58 107.85 27.86
P & G Health Ltd 6,502.50 944.52 934.17 33.02 71.75
Glaxosmi. Pharma 2,609.65 3,932.76 3,790.20 43.69 58.17
Cipla 1,466.00 20,102.60 18,979.95 38.53 13.88
Amrutanjan Healt 518.30 469.50 451.82 25.88 21.89
Fermenta Biotec. 465.55 474.15 450.25 21.32 18.77
Bliss GVS Pharma 454.10 773.53 729.81 49.74 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 33.64 19.52 3.94 23.52 6.77